Showing results (1491-1500 of 1,669) with videos related to

Sort By:
Pageof 167
Transplantation Proceedings|October 24, 2007
A rapid test of alloreactivity based on interleukin-2 mRNA expression might identify liver transplant recipients with donor-specific hyporesponsivenessL Craciun, P Stordeur, R Troisi, et al.
Computational Psychiatry (Cambridge, Mass.)|September 12, 2025
Computational Mechanisms of Approach-Avoidance Conflict Predictively Differentiate Between Affective and Substance Use DisordersMarishka M Mehta, Navid Hakimi, Orestes Pena, et al.
Nutrition & Metabolism|August 31, 2019
Lipid findings from the Diabetes Education to Lower Insulin, Sugars, and Hunger (DELISH) StudyAshley E Mason, Laura R Saslow, Patricia J Moran, et al.
Transplantation|March 1, 1990
Unrelated donor marrow transplantation between 1977 and 1987 at four centers in the United KingdomM R Howard, J M Hows, S M Gore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1982
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytesM B Prystowsky, J M Ely, D I Beller, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|March 12, 2005
Imaging procedures in adrenal pathologySuzan M Goldman, Rafael Darahem Coelho, Edison de O Freire Filho, et al.
Annals of Internal Medicine|June 1, 1988
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletionJ M Goldman, R P Gale, M M Horowitz, et al.
Blood|June 1, 1992
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaA J Barrett, M M Horowitz, R C Ash, et al.
Journal of Functional Biomaterials|June 26, 2024
A Two-Stage Approach Integrating Provisional Biomaterial-Mediated Stabilization Followed by a Definitive Treatment for Managing Volumetric Muscle Loss InjuriesAndrew R Clark, Jonathan Kulwatno, Sergey S Kanovka, et al.
The New England Journal of Medicine|October 10, 2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemiaTim P Hughes, Jaspal Kaeda, Susan Branford, et al.
Pageof 167